Furthermore, recent clinical studies have identified TRIM2 as a potential oncogene in human cancer cell lines including colorectal carcinoma, epithelial ovarian carcinoma and osteosarcoma [9,10,11]. The gene discussed is TRIM2; the disease is colorectal carcinoma.